论文部分内容阅读
美洛西林(mezlocillin)钠是一广谱半合成青霉素,已由山东沂蒙新华制药厂研制成功。1988年10月26日,在济南市召开了临床验证总结会,会上,由山东医科大学附院、山东省立医院、济南市传染病院各自介绍了1988年6-9月临床验证情况。专家们一致认为美洛西林是一高效(总有效率达90%以上)、安全、价格低廉的半合成青霉素,副作用少而轻微,无肝、肾等损伤作用,而且对β-内酰胺酶有一定的稳定性,对用
Mezlocillin sodium is a broad spectrum of semi-synthetic penicillin, which has been successfully developed by Shandong Yimeng Xinhua Pharmaceutical Factory. On October 26, 1988, a summary meeting of clinical validation was held in Jinan City. At the meeting, clinical validation of the cases from June to September 1988 was introduced by Shandong Medical University Affiliated Hospital, Shandong Provincial Hospital and Jinan Infectious Diseases Hospital respectively. Experts agree that mezlocillin is a highly effective (total effective rate of 90% or more), safe, inexpensive semisynthetic penicillin with few side effects, no liver, kidney and other injuries, and β-lactamase A certain stability, right